The AGILECATH brand, founded in 2003 (Belgium), from 2466 sister brands and 17477 competing brands. AGILECATH is owned by JOHNSON & JOHNSON, listed on the stock exchange of New York AGILECATH belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
JOHNSON & JOHNSON
(AGILECATH)
over 5 years*
USD 179.71